Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors

Peitao Zhang(Tianjin Medical University General Hospital), Li Zhao(Tianjin Medical University Cancer Institute and Hospital)
Nature Communications
March 24, 2022
Cited by 85


Related Papers